Diane Krause

The Krause lab focuses on hematopoiesis, leukemia, and cell therapies including bone marrow transplantation and PSC-based treatment for hypoparathyroidism.

[Diane Krause @Krauselab_Yale]

@therabbithole What number had 0 prior arrests? That would make this point if it's low. If it's high, then there isn't as much of
a point to make,

[Yale Cancer Center @YaleCancer]

Research led by @m_y_mayday uncovered how a mutant protein drives rare childhood leukemia #AMKL by hijacking RNA + Wnt signaling. Targeting these pathways with experimental inhibitors suppressed #leukemia growth. https://t.co/k2j8nLRuGo
@BloodPortfolio @Krauselab_Yale

[Diane Krause @Krauselab_Yale]

So proud of this team effort!

[OncLive.com @OncLive]

Yale Study: Potential Treatment Pathway Found for Rare and Aggressive Leukemia @m_y_mayday @BianconGiulia @tomalistar @Krauselab_Yale @Halene_lab @YaleCancer @YaleMed @BloodPortfolio #leusm #hematology
https://t.co/y9jVdHB9Gq

[Diane Krause @Krauselab_Yale]

@SenateGOP THE CUTS TO NIH THAT ARE ABOUT TO PASS WILL TANK THE ECOMONY!!!

[Diane Krause @Krauselab_Yale]

THE ECONOMY WILL FAIL WITH THE CUTS NIH FUNDING THAT ARE ABOUT TO PASS!!!!!!

[Lee Grimes Lab @LeeGrimesLab]

ASH Bridge Award direct cost floor was already raised to $500K/yr. Now the number of applications funded is dramatically increasing, with a rapid turn around...and a brand new additional cycle this year. @ASH_hematology

[Diane Krause @Krauselab_Yale]

Well said - this needs to go vira. https://t.co/ZJCa7aHLYM

[Diane Krause @Krauselab_Yale]

#saveNIH #SupportScience

[Diane Krause @Krauselab_Yale]

🚨 @elonmusk, we need your attention! 🚨

A proposed 40% cut to the NIH budget will have catastrophic consequences for patients, biotech, academics, and most importantly, our economy.

Here's why -->

[Diane Krause @Krauselab_Yale]

🚨 @elonmusk, we need your attention! 🚨

A proposed 40% cut to the NIH budget will have catastrophic consequences for patients, biotech, academics, and most importantly, our economy.

Here's why -->

[Diane Krause @Krauselab_Yale]

@m_y_mayday @BloodJournal Beautiful work, Madeline - you and the team should be very PROUD! Looking forward to clinical trials with WNT pathway inhibitors!

[Diane Krause @Krauselab_Yale]

@Lesdoggg And they still don't believe her.

[Diane Krause @Krauselab_Yale]

@EHA_Hematology 4

[Diane Krause @Krauselab_Yale]

@AlonsoTap @beastlet @weldeiry They don't care about science, scientific breakthroughs, the development of life saving drugs or the job creation that scientific discoveries is responsible for. They also don't care about trainees.

[Diane Krause @Krauselab_Yale]

.@rosadelauro @ChrisMurphyCT @SenBlumenthal Please continue to make medical research a priority by finalizing the FY2025 Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS) spending bill with a robust investment in the NIH as soon as possible.

[Diane Krause @Krauselab_Yale]

@The_Gilp Exactly how I feel!

[Diane Krause @Krauselab_Yale]

@anandi_krishnan @ncats_nih_gov So sorry, Anandi. You are a rising star in science and however your talents were identified and nurtured was the right approach!

[Diane Krause @Krauselab_Yale]

@drdianencefalon Have you heard that NIH won't fund it for sure?

[Diane Krause @Krauselab_Yale]

@Joshilabyale When they go low, we go high. I am busily reviewing some superb grants. Hopefully my review will be of some help to the investigators at some point.

If it were up to me, I would not have cancelled study sections - they have nothing to do with communication with the public.

[Diane Krause @Krauselab_Yale]

https://t.co/PGvr4vXt5u

[Diane Krause @Krauselab_Yale]

Why would the NIH cancel study sections in response to an Exec order to discontinue communication with the public? these are private and confidential meetings. the public is not there.